Cancer Center

Membership Guidelines

• Receive MCW Cancer Center publications and communications
• Invitation to Annual Research Retreat

Research and Clinical members may take advantage of the following benefits:

• Priority access and negotiated rates to use MCW Cancer Center shared resources (All members should acknowledge any use of shared resources in their research publications.)
• Opportunity to apply for MCW Cancer Center seed grant funding 
• Opportunities for leadership in cancer research
• Potential access to MCW Cancer Center space
• Membership listing on the MCW Cancer Center Website

• MCW academic appointment (Assistant Professor or above) or a professional appointment with MCW affiliated hospitals and organizations deemed appropriate by the Director
• Principal investigator of cancer-related, peer-reviewed* funded research OR Named investigator/collaborator of cancer-related, peer-reviewed* funded research OR Major contributor in the development and implementation of cancer-related institutional clinical trials AND a minimum of 5 patient clinical trial registrations per year
• Recent cancer-related publications (during the last three years) in peer-reviewed professional journals
• Clear commitment to participate in one or more MCW Cancer Center Research Programs
• Utilization of MCW Cancer Center shared resources (core facilities) as appropriate

• MCW academic appointment (Assistant Professor or Instructor) or a professional appointment with MCW affiliated hospitals and organizations deemed appropriate by the Director
• Actively pursuing cancer-related funding
• Recent cancer-related publications (during the last three years) in peer-reviewed professional journals
• Clear commitment to participate in one or more MCW Cancer Center Research Programs
• Utilization of MCW Cancer Center shared resources (core facilities) as appropriate

• MCW academic appointment (Assistant Professor or above) or a professional appointment with MCW affiliated hospitals and organizations deemed appropriate by the Director
• Significant professional involvement in cancer care and/or education
• Clear commitment to participate in the development of the MCW Cancer Center’s mission

• MCW academic appointment (Assistant Professor or above) or a professional appointment with MCW affiliated hospitals and organizations deemed appropriate by the Director

Application Process:

1. Read the membership criteria and determine which membership level is appropriate.
2. Complete the electronic application and email required documentation to Sheri Sasaki
3. Applicants will receive written notification of the decision indicating their type of membership following membership review.

• Cancer Susceptibility & Chemoprevention (Leaders: Gary Stoner, PhD and Ronald Hines, PhD)
• Cancer Cell Signaling and Metabolism (Leaders: Balaraman Kalyanaraman, PhD and Carol Williams, PhD)
• Angiogenesis, Metastasis & the Tumor Microenvironment (Leaders: Michael Dwinell, PhD and William Campbell, PhD)
• Cancer Imaging (Leaders: Kathleen Schmainda, PhD and Shi-Jiang Li, PhD)
• Hematologic Malignancy & Transplantation (Leader: William Drobyski, MD)
• Population Sciences (Leaders: Ann Nattinger, MD, MPH and Joan Neuner, MD, MPH)
• Experimental Therapeutics (Leader: James Thomas, MD, PhD)

• Awarded individual research grants, cooperative agreements and research contracts from the NCI including all awards with the following prefixes: R01, R03, R18, R21, R24, R25E, R29, R33, R35, R37, R41, R42, R43, R44, R55, P01 and P50 sub-projects, P30s other than the CCSG, U01, U54, U56, N01 research contracts and peer-reviewed, funded subcontracts of center members participating in collaborative research. (Note: Shared resources/cores of multi-component grants are not eligible for inclusion.)
• Components of National Cooperative Groups (e.g., U10s, U19s) funded by the NCI
• Individual research studies involving protocols approved by the NCI Cancer Therapy Evaluation Program (CTEP) and funded by NCI.
• Individual research studies involving prevention and control protocols approved by the NCI Cancer Control Protocol Review Committee and funded by NCI.
• Awarded research grants, cooperative agreements, and research contracts from other institutes of the NIH (same prefixes as above).

• Agency for Health Care Research and Quality (AHRQ)
• American Cancer Society (ACS): national office only
• American Foundation for AIDS Research (AFAR)
• American Institute for Cancer Research (AICR)
• Centers for Disease Control and Prevention (CDC)
• Central Office of the Veterans Administration (VA) - excluding local/regional awards and “block” grants
• Environmental Protection Agency (EPA)
• Florida Biomedical Research Program
• Food and Drug Administration (FDA)
• Howard Hughes Foundation
• Leukemia and Lymphoma Society
• Multiple Myeloma Research Foundation
• National Institute for Occupational Safety & Health
• National Science Foundation (NSF)
• Prevent Cancer Foundation
• Susan G. Komen for the Cure
• U.S. Army (DOD) special research programs in ovarian, breast & prostate cancer
• University of California-Wide Breast Cancer Research Programs